Search results
Results from the WOW.Com Content Network
Psilocybin is a psychedelic drug produced naturally by psilocybin mushrooms, commonly known as "magic mushrooms". [4] In the United States, it is federally classified as a Schedule I controlled substance that has "no accepted medical use and a high potential for abuse." [5] The drug was banned by the 1970 Controlled Substances Act. [6]
From 18 July 2005 [109] both fresh and "prepared" (that is, dried, cooked or made into a tea) psilocybin mushrooms became illegal in the United Kingdom; fresh mushrooms had previously been widely available, even in shops, but section 21 of the Drugs Act 2005 made fresh psychedelic mushrooms ("fungi containing psilocybin"), a Class A drug. [110]
[12] [15] The United States Food and Drug Administration has granted "breakthrough therapy" status, which expedites the potential approval of promising drug therapies, [note 2] to psychedelic therapies using psilocybin (for treatment-resistant depression and major depressive disorder) [6] and MDMA (for post-traumatic stress disorder).
Separately, state Rep. Dennis Tipsword, R-Metamora, expressed concern that Illinois could potentially legalize psilocybin, which is classified as a Schedule 1 drug under the Controlled Substances Act.
Two drug developers, Compass Pathways and Usona Institute, are conducting late-stage studies of psilocybin — the active ingredient in magic mushrooms — for severe depression.
FDA testing revealed a range of ingredients in Diamond Shruumz products, including a synthetic psychedelic similar to psilocybin, psilocin, a prescription anticonvulsant medication, muscimol, and ...
The drug or other substance has a high potential for abuse. The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. The complete list of Schedule I substances is as follows. [1]
Psilocybin, known colloquially as "magic mushrooms," is also working its way through the federal approval process, but it likely won't come up before officials for another year, Johnson said.